ID

40018

Descrizione

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT01432106

collegamento

https://clinicaltrials.gov/show/NCT01432106

Keywords

versioni (1)
  1. 09/03/20 09/03/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

9 marzo 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension NCT01432106

Inglese

Eligibility Hypertension NCT01432106

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. african american men or women 18 - 80 years of age.
Descrizione

African American | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085756
UMLS CUI [2]
C0001779
2. appropriate therapy for high blood pressure consisting of no more than 2 antihypertensives.
Descrizione

Antihypertensive therapy | Antihypertensive Agents Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0585941
UMLS CUI [2,1]
C0003364
UMLS CUI [2,2]
C1265611
3. patients with at least one marker of metabolic syndrome as evidenced by:
Descrizione

Marker Quantity Metabolic Syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0008963
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0524620
hdl cholesterol < 35mg/dl (men); < 45 mg/dl (women)
Descrizione

Serum HDL cholesterol measurement | Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0428472
UMLS CUI [2]
C0079399
triglycerides > 200mg/dl
Descrizione

Triglycerides measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0202236
fasting glucose >100mg/dl
Descrizione

Fasting blood glucose measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0428568
waist circumference: men >40 inches (102cm); women > 35 (88cm)
Descrizione

Waist Circumference | Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0455829
UMLS CUI [2]
C0079399
4. recent copy of ekg.
Descrizione

Copy EKG Recent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1948062
UMLS CUI [1,2]
C0013798
UMLS CUI [1,3]
C0332185
5. women able to become pregnant must use reliable contraception (e.g. hormonal contraception and double-barrier methods) throughout this study and for one week after the end of this study. post-menopausal or surgically sterile women.
Descrizione

Childbearing Potential Contraceptive methods | Hormonal contraception | Barrier Contraception Double | Postmenopausal state | Female Sterilization

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C2985296
UMLS CUI [3,1]
C0004764
UMLS CUI [3,2]
C0205173
UMLS CUI [4]
C0232970
UMLS CUI [5]
C0015787
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. uncontrolled hypertension.
Descrizione

Uncontrolled hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1868885
2. organ transplant.
Descrizione

Organ Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0029216
3. hypersensitivity to any study medications
Descrizione

Hypersensitivity Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
4. systolic pressure 170 or higher or diastolic pressure 110 or higher.
Descrizione

Systolic Pressure | Diastolic blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2]
C0428883
5. cardiovascular events within last 6 months stroke, heart attack, stent, or hospitalization for severe heart failure.
Descrizione

Cardiovascular event | Cerebrovascular accident | Myocardial Infarction | Placement of stent | Hospitalization Heart failure Severe

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1320716
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0522776
UMLS CUI [5,1]
C0019993
UMLS CUI [5,2]
C0018801
UMLS CUI [5,3]
C0205082
6. serum potassium greater than 5.0
Descrizione

Serum potassium measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0302353
7. heart block without a pacemaker, continuing arrhythmia or valvular heart disease.
Descrizione

Heart Block Without Pacemaker | Cardiac Arrhythmia | Heart valve disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0018794
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0810633
UMLS CUI [2]
C0003811
UMLS CUI [3]
C0018824
8. blocked renal artery.
Descrizione

Renal artery occlusion

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0553718
9. patients with severe renal impairment (creatinine 1.7 mg/dl for women and 2.0 mg/dl for men and or estimated gfr <30 ml/min) a history of dialysis, nephritic syndrome, or reno-vascular hypertension.
Descrizione

Renal Insufficiency Severe | Creatinine measurement, serum | Gender | Estimated Glomerular Filtration Rate | Dialysis | Nephritic syndrome | Hypertension, Renovascular

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0079399
UMLS CUI [4]
C3811844
UMLS CUI [5]
C0011946
UMLS CUI [6]
C0268732
UMLS CUI [7]
C0020545
10. any condition that may alter medication absorption.
Descrizione

Condition Changing Drug absorption

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0392747
UMLS CUI [1,3]
C0678745
11. any condition that may place patient at higher risk from participating in study or will jeopardize the evaluation of efficacy or safety.
Descrizione

Condition Study Subject Participation Status High risk | Condition Evaluation At risk

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C4319571
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C1261322
UMLS CUI [2,3]
C1444641
12. use of any investigational study medications within 30 days of enrollment
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
13. persons unwilling or unable to take regular medications or comply with study protocol.
Descrizione

Medication Regular Unwilling | Medication Regular Unable | Protocol Compliance Unwilling | Protocol Compliance Unable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0205272
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0205272
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0525058
UMLS CUI [3,2]
C0558080
UMLS CUI [4,1]
C0525058
UMLS CUI [4,2]
C1299582
14. pregnant or nursing (lactating) women, or women of childbearing potential (defined as all women physiologically capable of becoming pregnant) who do not use reliable methods of contraception: surgical sterilization, bilateral tubal ligation, hormonal contraception, implantable and oral) and double barrier methods if accepted by local regulatory authority and ethics committee. reliable contraception should be maintained throughout the study and for 7 days after study drug discontinuation.
Descrizione

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Absent | Female Sterilization | Bilateral tubal ligation | Hormonal contraception | Contraceptive implant Hormonal | Contraceptives, Oral, Hormonal | Barrier Contraception Double

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0332197
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0589114
UMLS CUI [6]
C2985296
UMLS CUI [7,1]
C1657106
UMLS CUI [7,2]
C0458083
UMLS CUI [8]
C0009907
UMLS CUI [9,1]
C0004764
UMLS CUI [9,2]
C0205173
Ritorna all'inizio della pagina

Similar models

Eligibility Hypertension NCT01432106

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
African American | Age
Item
1. african american men or women 18 - 80 years of age.
boolean
C0085756 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Antihypertensive therapy | Antihypertensive Agents Quantity
Item
2. appropriate therapy for high blood pressure consisting of no more than 2 antihypertensives.
boolean
C0585941 (UMLS CUI [1])
C0003364 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Marker Quantity Metabolic Syndrome
Item
3. patients with at least one marker of metabolic syndrome as evidenced by:
boolean
C0008963 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0524620 (UMLS CUI [1,3])
Serum HDL cholesterol measurement | Gender
Item
hdl cholesterol < 35mg/dl (men); < 45 mg/dl (women)
boolean
C0428472 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Triglycerides measurement
Item
triglycerides > 200mg/dl
boolean
C0202236 (UMLS CUI [1])
Fasting blood glucose measurement
Item
fasting glucose >100mg/dl
boolean
C0428568 (UMLS CUI [1])
Waist Circumference | Gender
Item
waist circumference: men >40 inches (102cm); women > 35 (88cm)
boolean
C0455829 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Copy EKG Recent
Item
4. recent copy of ekg.
boolean
C1948062 (UMLS CUI [1,1])
C0013798 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Childbearing Potential Contraceptive methods | Hormonal contraception | Barrier Contraception Double | Postmenopausal state | Female Sterilization
Item
5. women able to become pregnant must use reliable contraception (e.g. hormonal contraception and double-barrier methods) throughout this study and for one week after the end of this study. post-menopausal or surgically sterile women.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C2985296 (UMLS CUI [2])
C0004764 (UMLS CUI [3,1])
C0205173 (UMLS CUI [3,2])
C0232970 (UMLS CUI [4])
C0015787 (UMLS CUI [5])
Item Group
C0680251 (UMLS CUI)
Uncontrolled hypertension
Item
1. uncontrolled hypertension.
boolean
C1868885 (UMLS CUI [1])
Organ Transplantation
Item
2. organ transplant.
boolean
C0029216 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs
Item
3. hypersensitivity to any study medications
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Systolic Pressure | Diastolic blood pressure
Item
4. systolic pressure 170 or higher or diastolic pressure 110 or higher.
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
Cardiovascular event | Cerebrovascular accident | Myocardial Infarction | Placement of stent | Hospitalization Heart failure Severe
Item
5. cardiovascular events within last 6 months stroke, heart attack, stent, or hospitalization for severe heart failure.
boolean
C1320716 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0522776 (UMLS CUI [4])
C0019993 (UMLS CUI [5,1])
C0018801 (UMLS CUI [5,2])
C0205082 (UMLS CUI [5,3])
Serum potassium measurement
Item
6. serum potassium greater than 5.0
boolean
C0302353 (UMLS CUI [1])
Heart Block Without Pacemaker | Cardiac Arrhythmia | Heart valve disease
Item
7. heart block without a pacemaker, continuing arrhythmia or valvular heart disease.
boolean
C0018794 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0810633 (UMLS CUI [1,3])
C0003811 (UMLS CUI [2])
C0018824 (UMLS CUI [3])
Renal artery occlusion
Item
8. blocked renal artery.
boolean
C0553718 (UMLS CUI [1])
Renal Insufficiency Severe | Creatinine measurement, serum | Gender | Estimated Glomerular Filtration Rate | Dialysis | Nephritic syndrome | Hypertension, Renovascular
Item
9. patients with severe renal impairment (creatinine 1.7 mg/dl for women and 2.0 mg/dl for men and or estimated gfr <30 ml/min) a history of dialysis, nephritic syndrome, or reno-vascular hypertension.
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C3811844 (UMLS CUI [4])
C0011946 (UMLS CUI [5])
C0268732 (UMLS CUI [6])
C0020545 (UMLS CUI [7])
Condition Changing Drug absorption
Item
10. any condition that may alter medication absorption.
boolean
C0348080 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
Condition Study Subject Participation Status High risk | Condition Evaluation At risk
Item
11. any condition that may place patient at higher risk from participating in study or will jeopardize the evaluation of efficacy or safety.
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C4319571 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C1261322 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
Investigational New Drugs
Item
12. use of any investigational study medications within 30 days of enrollment
boolean
C0013230 (UMLS CUI [1])
Medication Regular Unwilling | Medication Regular Unable | Protocol Compliance Unwilling | Protocol Compliance Unable
Item
13. persons unwilling or unable to take regular medications or comply with study protocol.
boolean
C0013227 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0525058 (UMLS CUI [3,1])
C0558080 (UMLS CUI [3,2])
C0525058 (UMLS CUI [4,1])
C1299582 (UMLS CUI [4,2])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Absent | Female Sterilization | Bilateral tubal ligation | Hormonal contraception | Contraceptive implant Hormonal | Contraceptives, Oral, Hormonal | Barrier Contraception Double
Item
14. pregnant or nursing (lactating) women, or women of childbearing potential (defined as all women physiologically capable of becoming pregnant) who do not use reliable methods of contraception: surgical sterilization, bilateral tubal ligation, hormonal contraception, implantable and oral) and double barrier methods if accepted by local regulatory authority and ethics committee. reliable contraception should be maintained throughout the study and for 7 days after study drug discontinuation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0015787 (UMLS CUI [4])
C0589114 (UMLS CUI [5])
C2985296 (UMLS CUI [6])
C1657106 (UMLS CUI [7,1])
C0458083 (UMLS CUI [7,2])
C0009907 (UMLS CUI [8])
C0004764 (UMLS CUI [9,1])
C0205173 (UMLS CUI [9,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial